C.D.C. Panel Recommends Other Covid Vaccines Over J.&J.’s Shots
A committee of experts voted on a preference for the Moderna or Pfizer immunizations, citing the risk of blood clots linked to Johnson & Johnson’s product.
View original article
Contributor: Rebecca Robbins and Christina Jewett
